nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicoumarol—GPR35—nervous system—multiple sclerosis	0.103	0.127	CbGeAlD
Dicoumarol—GPR35—central nervous system—multiple sclerosis	0.0995	0.122	CbGeAlD
Dicoumarol—GPR35—brain—multiple sclerosis	0.079	0.0968	CbGeAlD
Dicoumarol—CRYZ—medulla oblongata—multiple sclerosis	0.0512	0.0628	CbGeAlD
Dicoumarol—CRYZ—midbrain—multiple sclerosis	0.0468	0.0574	CbGeAlD
Dicoumarol—CRYZ—spinal cord—multiple sclerosis	0.0457	0.056	CbGeAlD
Dicoumarol—CRYZ—Azacitidine—Cladribine—multiple sclerosis	0.0433	1	CbGdCrCtD
Dicoumarol—CRYZ—nervous system—multiple sclerosis	0.0385	0.0472	CbGeAlD
Dicoumarol—CRYZ—central nervous system—multiple sclerosis	0.0371	0.0454	CbGeAlD
Dicoumarol—CRYZ—cerebellum—multiple sclerosis	0.0362	0.0444	CbGeAlD
Dicoumarol—NQO1—retina—multiple sclerosis	0.0302	0.0371	CbGeAlD
Dicoumarol—CRYZ—brain—multiple sclerosis	0.0294	0.0361	CbGeAlD
Dicoumarol—VKORC1—nervous system—multiple sclerosis	0.0265	0.0325	CbGeAlD
Dicoumarol—VKORC1—central nervous system—multiple sclerosis	0.0255	0.0313	CbGeAlD
Dicoumarol—VKORC1—cerebellum—multiple sclerosis	0.0249	0.0306	CbGeAlD
Dicoumarol—NQO1—medulla oblongata—multiple sclerosis	0.0219	0.0268	CbGeAlD
Dicoumarol—VKORC1—brain—multiple sclerosis	0.0203	0.0248	CbGeAlD
Dicoumarol—NQO1—midbrain—multiple sclerosis	0.02	0.0245	CbGeAlD
Dicoumarol—NQO1—spinal cord—multiple sclerosis	0.0195	0.0239	CbGeAlD
Dicoumarol—NQO1—nervous system—multiple sclerosis	0.0164	0.0201	CbGeAlD
Dicoumarol—NQO1—central nervous system—multiple sclerosis	0.0158	0.0194	CbGeAlD
Dicoumarol—NQO1—cerebellum—multiple sclerosis	0.0155	0.0189	CbGeAlD
Dicoumarol—NQO1—brain—multiple sclerosis	0.0126	0.0154	CbGeAlD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.0107	0.0897	CbGpPWpGaD
Dicoumarol—Acenocoumarol—ALB—multiple sclerosis	0.0103	0.469	CrCbGaD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00977	0.082	CbGpPWpGaD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.0067	0.0563	CbGpPWpGaD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00647	0.0543	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—IL7R—multiple sclerosis	0.00644	0.0541	CbGpPWpGaD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.0063	0.0529	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.00625	0.0525	CbGpPWpGaD
Dicoumarol—Phenprocoumon—ALB—multiple sclerosis	0.00616	0.281	CrCbGaD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00581	0.0488	CbGpPWpGaD
Dicoumarol—Warfarin—ALB—multiple sclerosis	0.00546	0.249	CrCbGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—SRM—multiple sclerosis	0.00415	0.0349	CbGpPWpGaD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00406	0.0341	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.00393	0.033	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—VDR—multiple sclerosis	0.0026	0.0218	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00254	0.0213	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00254	0.0213	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—FAS—multiple sclerosis	0.00226	0.019	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—multiple sclerosis	0.00211	0.0177	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.00169	0.0142	CbGpPWpGaD
Dicoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00161	0.0135	CbGpPWpGaD
Dicoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00161	0.0135	CbGpPWpGaD
Dicoumarol—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00159	0.0133	CbGpPWpGaD
Dicoumarol—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00159	0.0133	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.00151	0.0126	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.0015	0.0126	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—SLC30A7—multiple sclerosis	0.00148	0.0124	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00131	0.011	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00131	0.011	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—PABPC1—multiple sclerosis	0.0012	0.01	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.00117	0.00985	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.00117	0.00983	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.00115	0.00964	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.00109	0.00918	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.00109	0.00918	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—RPL5—multiple sclerosis	0.00108	0.00906	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—MAPK1—multiple sclerosis	0.00102	0.0086	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—multiple sclerosis	0.000976	0.00819	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00083	0.00697	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—BCHE—multiple sclerosis	0.00079	0.00663	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—SRM—multiple sclerosis	0.000762	0.0064	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000693	0.00582	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000693	0.00582	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000684	0.00574	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000684	0.00574	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CYP27B1—multiple sclerosis	0.000537	0.00451	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CYP24A1—multiple sclerosis	0.000537	0.00451	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GPC5—multiple sclerosis	0.000491	0.00413	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—TGFB1—multiple sclerosis	0.000465	0.0039	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—POMC—multiple sclerosis	0.000408	0.00343	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—RRM1—multiple sclerosis	0.000407	0.00342	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—CCL2—multiple sclerosis	0.000399	0.00335	CbGpPWpGaD
Dicoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000362	0.00304	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000294	0.00247	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000266	0.00224	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000266	0.00224	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—BCHE—multiple sclerosis	0.000234	0.00196	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—SRM—multiple sclerosis	0.000168	0.00141	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—POMC—multiple sclerosis	0.000156	0.00131	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—APOE—multiple sclerosis	0.000141	0.00118	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—POMC—multiple sclerosis	0.000121	0.00101	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	0.000119	0.000996	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	0.000119	0.000996	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000116	0.000973	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ALB—multiple sclerosis	0.00011	0.000925	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GPC5—multiple sclerosis	0.000108	0.000911	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—RRM1—multiple sclerosis	8.99e-05	0.000755	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.97e-05	0.000585	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.99e-05	0.000503	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.46e-05	0.000459	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—BCHE—multiple sclerosis	5.16e-05	0.000433	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—APOE—multiple sclerosis	3.11e-05	0.000261	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—POMC—multiple sclerosis	2.67e-05	0.000224	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ALB—multiple sclerosis	2.43e-05	0.000204	CbGpPWpGaD
